Page last updated: 2024-12-07

technetium tc 99m hydroxymethylene diphosphonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

technetium Tc 99m hydroxymethylene diphosphonate: bone-seeking radiopharmaceutical [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123801
MeSH IDM0082205

Synonyms (26)

Synonym
technetium hmdp
technetium tc-99m oxidronate
99mtc-hdp
technetium tc-99m oxidronate kit
technetium tc 99m oxidronate
technetium 99mtc oxidronate
72945-61-0
phosphonic acid, (hydroxymethylene)bis-, technetium-99tc salt
tc-99m-hdp
technetium salt (hydroxymethylene)bis(phosphonic acid)
technetium-99mtc-methylene diphosphonate
technetium osteoscan-hdp
mg4ki49hhj ,
tc-99m-hmdp
technescan
technetium tc 99m hydroxymethylene diphosphonate
tc-99m hydroxymethylene diphosphonate
unii-mg4ki49hhj
technescan hdp
tc-99m-oxidronate
technetium tc 99m oxidronate [who-dd]
technetium tc 99m oxidronate [usp impurity]
technetium (99mtc) oxidronate
DB09139
Q22075854
[hydroxy(phosphono)methyl]phosphonic acid;technetium-99

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" There was no dose-response relationship between the dose of APD given and the percentage reduction in ALP and HYPRO at 6 months."( Bisphosphonate space measurement in Paget's disease of bone treated with APD.
Evans, AJ; Hosking, DJ; Marshall, DH; Perkins, AC; Stone, MD; Wastie, ML, 1992
)
0.28
" The resulting scintiphotos were superimposed on lower GI radiographs to determine the extent of spreading of the dosage form in the rectum."( Disposition of radiolabelled suppositories in humans.
Beihn, RM; Caldwell, L; Deland, FH; Digenis, GA; Jay, M; Mlodozeniec, AR, 1985
)
0.27
" Two levels of dosage (1."( Strontium-89 therapy and imaging with bremsstrahlung in bone metastases.
Fukumitsu, N; Kawakami, K; Makino, M; Mori, Y; Narita, H; Sekine, H; Uchiyama, M, 1997
)
0.3
" For bone-scan it was used intravenously instilled disfonate compound marked with 99 mTc-HMDP-"Osteocis" in the dosage of 740 MBq."( [Scintigraphy in the early diagnosis of the secondary hypertrophic osteoarthropathy syndrome].
Jajić, I; Jajić, Z; Kovacić, K, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (578)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990124 (21.45)18.7374
1990's201 (34.78)18.2507
2000's163 (28.20)29.6817
2010's72 (12.46)24.3611
2020's18 (3.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 8.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index8.03 (24.57)
Research Supply Index6.48 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (8.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials35 (5.66%)5.53%
Reviews14 (2.27%)6.00%
Case Studies309 (50.00%)4.05%
Observational2 (0.32%)0.25%
Other258 (41.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]